Stocks hovered around the flat line in midday trading Monday with the Dow and the S&P 500 slightly down and the Nasdaq inching slightly higher. Crude oil also a bit lower at $59.18 a barrel. Shares of drug-maker Actavis (ACT) were rising after the company beat earnings estimates. Actavis reported adjusted quarterly profit of $4.30 a share, topping estimates of $3.93 a share. Revenue also topped expectations, helped by higher sales of its drugs in North America. And in the latest deal spurred by lower oil prices, Rosetta Resources (ROSE) shares were surging after Noble Energy (NBL) said it would acquire the energy company for $2.1 billion in stock. Noble will also assume Rosetta's net debt of $1.8 billion as of March 31.
More from Video
Amid the Selling, Here's the Big Question Now
How quickly do we find support, is what we'll want to know now, as the correction is occurring while economic optimism builds.
One Tweet Pulls the Rug Out From Under the Indexes
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
A Technical Look at the New Dow Jones Industrial Average
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
Conagra Brands Looks Tastier After Its Upgrade to Buy
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Biogen Bulls Get a Lift From Quant Upgrade and Strengthening Charts
Breaking down an approach to the long side of this biotech stock.
Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation.
If you have questions, please contact us here.